| 英文别名 |
2-Cyclohexen-1-one,4-hydroxy-4-[(1E,3R)-3-hydroxy-1-buten-1-yl]-3,5,5-trimethyl-, (4S)-;Blumenol A;(4S)-4-hydroxy-4-[(E,3R)-3-hydroxybut-1-enyl]-3,5,5-trimethylcyclohex-2-en-1-one;VOMIFOLIOL;Vomifoliol;FS-9636;2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-buten-1-yl)-3,5,5-trimethyl-, (4S)-;4-Hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-2-cyclohexen-1-one, (4S,3R)-(E)-(+/-)-;Vomifoliol, (+)-;NSC805019;50763-73-0;NS00122932;2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-buten-1-yl)-3,5,5-trimethyl-, (4S)-rel-;(4S)-4-hydroxy-4-[(1E,3R)-3-hydroxybut-1-enyl]-3,5,5-trimethylcyclohex-2-en-1-one;CHEMBL463088;HY-N1077;B7QV234K84;(4S)-4-hydroxy-4-[(1E,3R)-3-hydroxybut-1-en-1-yl]-3,5,5-trimethylcyclohex-2-en-1-one;2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (R*,S*-(E))-(+/-)-;2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (4S)-;CHEBI:49164;(6S,9R)-6-HYDROXY-3-OXO-.ALPHA.-IONOL;2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (+-)-;2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (R*,S*-(E))-;(+)-Vomifoliol;BDBM50463336;DTXSID601009964;(S)-4-Hydroxy-4-((R,E)-3-hydroxybut-1-en-1-yl)-3,5,5-trimethylcyclohex-2-en-1-one;23526-45-6;(+-)-Blumenol A;BLUMENOL A;(6S,7E,9R)-6,9-dihydroxy-4,7-megastigmadien-3-one;(6S,9R)-6-hydroxy-3-oxo-alpha-ionol;2-CYCLOHEXEN-1-ONE, 4-HYDROXY-4-(3-HYDROXY-1-BUTENYL)-3,5,5-TRIMETHYL-, (+)-;(+/-)-Blumenol-A;SCHEMBL1243896;CS-0016364;FEMA no. 4661, (4S,3R)-(E)-(+/-)-;2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (S-(R*,S*-(E)))-;Roseoside aglycon;KPQMCAKZRXOZLB-KOIHBYQTSA-N;(+)-BLUMENOL A;(6S,9R)-vomifoliol;Vomifoliol, (+-)-;UNII-P86438KC5J;UNII-B7QV234K84;AKOS032948398;Q22911785;(+-)-6-hydroxy-3-oxo-alpha-ionol;(+/-)-Volifoliol;C01760;P86438KC5J;(+-)-Vomifoliol;NSC-805019;vomifoliol;(+)-Blumenol A;(6S,9R)-6-Hydroxy-3-oxo-alpha-ionol |
微信公众号
客服
